Literature DB >> 2786004

Observer agreement in the assessment of clinical signs in experimental allergic encephalomyelitis.

I Matthaei1, C H Polman, C J de Groot, C D Dijkstra, J C Koetsier, T Sminia.   

Abstract

Rats suffering from experimental allergic encephalomyelitis (EAE) were examined by a number of investigators whose assessments were compared. Considerable consensus of opinion was reached, especially when a standard, easily interpretable, scoring classification was used. More discrepancies occurred when a more expanded scale, differentiating between more clinical grades, was used. It is demonstrated that part of these discrepancies can be overcome by having the examinations done by the same investigator. Possible consequences of these findings for the assessment of clinical signs in EAE are discussed.

Entities:  

Mesh:

Year:  1989        PMID: 2786004     DOI: 10.1016/0165-5728(89)90068-4

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  6 in total

1.  Dynamics of sodium channel Nav1.5 expression in astrocytes in mouse models of multiple sclerosis.

Authors:  Laura W Pappalardo; Shujun Liu; Joel A Black; Stephen G Waxman
Journal:  Neuroreport       Date:  2014-10-22       Impact factor: 1.837

2.  Suppression of experimental allergic encephalomyelitis by intraventricular administration of interferon-gamma in Lewis rats.

Authors:  J A Voorthuis; B M Uitdehaag; C J De Groot; P H Goede; P H van der Meide; C D Dijkstra
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

3.  Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors.

Authors:  S R Ruuls; S Van Der Linden; K Sontrop; I Huitinga; C D Dijkstra
Journal:  Clin Exp Immunol       Date:  1996-03       Impact factor: 4.330

4.  Transport of a hydrophilic compound into the cerebrospinal fluid during experimental allergic encephalomyelitis and after lipopolysaccharide administration.

Authors:  H E de Vries; E F Eppens; M Prins; J Kuiper; T J van Berkel; A G de Boer; D D Breimer
Journal:  Pharm Res       Date:  1995-12       Impact factor: 4.200

5.  Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages.

Authors:  I Huitinga; N van Rooijen; C J de Groot; B M Uitdehaag; C D Dijkstra
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

6.  Interleukin-1β and interleukin-1 receptor antagonist appear in grey matter additionally to white matter lesions during experimental multiple sclerosis.

Authors:  Marloes Prins; Charlotta Eriksson; Anne Wierinckx; John G J M Bol; Rob Binnekade; Fred J H Tilders; Anne-Marie Van Dam
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.